Literature DB >> 24424504

Androgen receptor phosphorylation: biological context and functional consequences.

Yulia Koryakina1, Huy Q Ta1, Daniel Gioeli2.   

Abstract

The androgen receptor (AR) is a ligand-regulated transcription factor that belongs to the family of nuclear receptors. In addition to regulation by steroid, the AR is also regulated by post-translational modifications generated by signal transduction pathways. Thus, the AR functions not only as a transcription factor but also as a node that integrates multiple extracellular signals. The AR plays an important role in many diseases, including complete androgen insensitivity syndrome, spinal bulbar muscular atrophy, prostate and breast cancer, etc. In the case of prostate cancer, dependence on AR signaling has been exploited for therapeutic intervention for decades. However, the effectiveness of these therapies is limited in advanced disease due to restoration of AR signaling. Greater understanding of the molecular mechanisms involved in AR action will enable the development of improved therapeutics to treat the wide range of AR-dependent diseases. The AR is subject to regulation by a number of kinases through post-translational modifications on serine, threonine, and tyrosine residues. In this paper, we review the AR phosphorylation sites, the kinases responsible for these phosphorylations, as well as the biological context and the functional consequences of these phosphorylations. Finally, what is known about the state of AR phosphorylation in clinical samples is discussed.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  androgen receptor; cell signaling; gene transcription; growth factor; prostate

Mesh:

Substances:

Year:  2014        PMID: 24424504      PMCID: PMC4437516          DOI: 10.1530/ERC-13-0472

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  74 in total

1.  Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models.

Authors:  C Nessler-Menardi; I Jotova; Z Culig; I E Eder; T Putz; G Bartsch; H Klocker
Journal:  Prostate       Date:  2000-10-01       Impact factor: 4.104

2.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 3.  Overview of the generation, validation, and application of phosphosite-specific antibodies.

Authors:  Kathy Brumbaugh; Wade Johnson; Wen-Chieh Liao; Mong-Shang Lin; J P Houchins; Jeff Cooper; Steven Stoesz; Roberto Campos-Gonzalez
Journal:  Methods Mol Biol       Date:  2011

4.  Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor.

Authors:  H K Lin; S Yeh; H Y Kang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

5.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome.

Authors:  D B Lubahn; D R Joseph; P M Sullivan; H F Willard; F S French; E M Wilson
Journal:  Science       Date:  1988-04-15       Impact factor: 47.728

6.  Post-translational modification of the androgen receptor.

Authors:  Daniel Gioeli; Bryce M Paschal
Journal:  Mol Cell Endocrinol       Date:  2011-07-24       Impact factor: 4.102

7.  Growth inhibitory effects of the dual ErbB1/ErbB2 tyrosine kinase inhibitor PKI-166 on human prostate cancer xenografts.

Authors:  Ingo K Mellinghoff; Chris Tran; Charles L Sawyers
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

8.  An androgen receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP).

Authors:  Bin He; Suxia Bai; Andrew T Hnat; Rebecca I Kalman; John T Minges; Cam Patterson; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2004-04-23       Impact factor: 5.157

Review 9.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28

10.  Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.

Authors:  Liliana A Ponguta; Christopher W Gregory; Frank S French; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2008-05-29       Impact factor: 5.157

View more
  35 in total

1.  Inhibition of IGF-1R diminishes transcriptional activity of the androgen receptor and its constitutively active, C-terminally truncated counterparts Q640X and AR-V7.

Authors:  Friedemann Zengerling; Anca Azoitei; Alexander Herweg; Florian Jentzmik; Marcus V Cronauer
Journal:  World J Urol       Date:  2015-08-29       Impact factor: 4.226

2.  Phosphorylation of androgen receptor serine 81 is associated with its reactivation in castration-resistant prostate cancer.

Authors:  Joshua W Russo; Xiaming Liu; Huihui Ye; Carla Calagua; Sen Chen; Olga Voznesensky; James Condulis; Fen Ma; Mary-Ellen Taplin; David J Einstein; Steven P Balk; Shaoyong Chen
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

3.  MAPK, androgen, and glucocorticoid receptor phosphorylation following high-frequency resistance exercise non-functional overreaching.

Authors:  Justin X Nicoll; Andrew C Fry; Eric M Mosier; Luke A Olsen; Stephanie A Sontag
Journal:  Eur J Appl Physiol       Date:  2019-08-16       Impact factor: 3.078

4.  Therapeutic Targeting of Sunitinib-Induced AR Phosphorylation in Renal Cell Carcinoma.

Authors:  Remi Adelaiye-Ogala; Nur P Damayanti; Ashley R Orillion; Sreevani Arisa; Sreenivasulu Chintala; Mark A Titus; Chinghai Kao; Roberto Pili
Journal:  Cancer Res       Date:  2018-03-23       Impact factor: 12.701

5.  Could the kinetin riboside be used to inhibit human prostate cell epithelial-mesenchymal transition?

Authors:  Joanna Dulińska-Litewka; Bartosz Gąsiorkiewicz; Aleksandra Litewka; Dorota Gil; Tomasz Gołąbek; Krzysztof Okoń
Journal:  Med Oncol       Date:  2020-02-06       Impact factor: 3.064

6.  Cell-cycle-dependent regulation of androgen receptor function.

Authors:  Yulia Koryakina; Karen E Knudsen; Daniel Gioeli
Journal:  Endocr Relat Cancer       Date:  2015-02-17       Impact factor: 5.678

7.  αvβ6 Integrin Promotes Castrate-Resistant Prostate Cancer through JNK1-Mediated Activation of Androgen Receptor.

Authors:  Huimin Lu; Tao Wang; Jing Li; Carmine Fedele; Qin Liu; Jianzhong Zhang; Zhong Jiang; Dhanpat Jain; Renato V Iozzo; Shelia M Violette; Paul H Weinreb; Roger J Davis; Daniel Gioeli; Thomas J FitzGerald; Dario C Altieri; Lucia R Languino
Journal:  Cancer Res       Date:  2016-07-22       Impact factor: 12.701

Review 8.  Molecular Subtypes of Prostate Cancer.

Authors:  Kaveri Arora; Christopher E Barbieri
Journal:  Curr Oncol Rep       Date:  2018-06-01       Impact factor: 5.075

9.  Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptor‑mediated signaling.

Authors:  Shan Lu; Zhongyun Dong
Journal:  Int J Oncol       Date:  2021-05-13       Impact factor: 5.650

Review 10.  The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance.

Authors:  Ryan Cronin; Greg N Brooke; Filippo Prischi
Journal:  Oncogene       Date:  2021-05-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.